The Hopkins-based pharmaceutical ingredient maker Nu-Tek BioSciences broke ground Tuesday on a $40 million factory in Austin, Minn., that is expected to create 35 to 40 new jobs.
Once completed next year, the 60,000 square-foot biotech plant will be used to make animal-free peptone proteins that can be used to grow bacteria and other cultures in a lab. The factory is being touted as the first in the United States to focus on proteins that are free of animal tissue.
Officials cited growing demand for animal-free options but said the new factory was also needed to help mitigate worldwide supply chain risks that skyrocketed during the pandemic.
Nu-Tek supplies a key component used in the manufacture of one of the COVID-19 vaccines, so timely delivery is critical, company officials said.
CEO Thomas Yezzi said the new Minnesota project, which includes an option to buy more land in Austin for expansion, builds upon a decade catering to the bio-tech industry.
"For more than 10 years, Nu-Tek has manufactured and supplied raw materials in the form of peptones to the pharmaceutical industry," Yezzi said. "Austin's rich manufacturing background and proximity to world-class health care systems and major research universities made it the ideal location to build a world-class facility needed to manufacture next generation biologics."
Minnesota's Department of Employment and Economic Development (DEED) is assisting in the project with a $325,000 loan from the Minnesota Investment Fund and a $175,000 award from the Job Creation Fund.
The state has long supported bio-tech manufacturing projects because they create high skilled jobs that pay well. Under terms of the Job Creation Fund, Nu-Tek is required to create the 35 to 40 jobs over an estimated two year period.